nach oben

Internal and Emergency Medicine

Erschienen in:

17.07.2019 | IM - Commentary

Atrial fibrillation and kidney disease: insights on a close relationship

verfasst von: Giorgio Trivioli

Erschienen in: Internal and Emergency Medicine | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Excerpt

The association between atrial fibrillation (AFib) and kidney disease is common but represents a challenge for clinicians, since patients experience significant morbidity and mortality and require a careful management [1, 2]. These two diseases have a similar distribution in the general population, with prevalence increasing with age, and share several risk factors, including hypertension, diabetes and cardiovascular disease [3, 4]. Recent observations have highlighted that they are closely related and each predisposes to the development of the other. …

Wetmore JB, Ellerbeck EF, Mahnken JD et al (2013) Atrial fibrillation and risk of stroke in dialysis patients. Ann Epidemiol 23(3):112–118CrossRefPubMedPubMedCentral

Bhatia HS, Hsu JC, Kim RJ (2018) Atrial fibrillation and chronic kidney disease: a review of options for therapeutic anticoagulation to reduce thromboembolism risk. Clin Cardiol 41(10):1395–1402CrossRefPubMedPubMedCentral

Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271(11):840–844CrossRefPubMed

Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140(3):167–174CrossRefPubMed

Alonso A, Lopez FL, Matsushita K et al (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Circulation 123(25):2946–2953CrossRefPubMedPubMedCentral

Bansal N, Zelnick LR, Alonso A et al (2017) eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. CJASN 12(9):1386–1398CrossRefPubMed

Hu WS, Lin CL (2019) Risk of new-onset atrial fibrillation among heart, kidney and liver transplant recipients: insights from a national cohort study. Intern Emerg Med 14(1):71–76CrossRefPubMed

Genovesi S, Pogliani D, Faini A et al (2005) Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46(5):897–902CrossRefPubMed

Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158(4):629–636CrossRefPubMed

10.

Bansal N, Xie D, Tao K et al (2016) Atrial fibrillation and risk of ESRD in adults with CKD. CJASN 11(7):1189–1196CrossRefPubMed

11.

Albahrani MJ, Swaminathan M, Phillips-Bute B et al (2003) Postcardiac surgery complications: association of acute renal dysfunction and atrial fibrillation. Anesth Analg 96(3):637–643CrossRefPubMed

12.

Hu WS, Lin CL (2019) Comparison of incidence of acute kidney injury, chronic kidney disease and end-stage renal disease between atrial fibrillation and atrial flutter: real-world evidences from a propensity score-matched national cohort analysis. Intern Emerg Med 9:1–6

13.

Chao TF, Liu CJ, Liao JN et al (2016) Use of oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage. Circulation 133(16):1540–1547CrossRefPubMed

14.

Chao TF, Lip GY, Liu CJ et al (2016) Validation of a modified CHA2DS2-VASc score for stroke risk stratification in asian patients with atrial fibrillation: a nationwide cohort study. Stroke 47(10):2462–2469CrossRefPubMed

15.

Liao JN, Chao TF, Liu CJ et al (2015) Risk and prediction of dementia in patients with atrial fibrillation–a nationwide population-based cohort study. Int J Cardiol 199:25–30CrossRefPubMed

16.

Chung MK, Martin DO, Sprecher D et al (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104(24):2886–2891CrossRefPubMed

17.

Aviles RJ, Martin DO, Apperson-Hansen C et al (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108(24):3006–3010CrossRefPubMed

18.

Acevedo M, Corbalan R, Braun S, Pereira J, Navarrete C, Gonzalez I (2006) C-reactive protein and atrial fibrillation: “evidence for the presence of inflammation in the perpetuation of the arrhythmia”. Int J Cardiol 108(3):326–331CrossRefPubMed

19.

Pellegrino PL, Brunetti ND, De Gennaro L, Ziccardi L, Grimaldi M, Biase MD (2013) Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset. Intern Emerg Med 8(2):123–128CrossRefPubMed

20.

Shlipak MG, Fried LF, Crump C et al (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107(1):87–92CrossRefPubMed

21.

Fried L, Solomon C, Shlipak M et al (2004) Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. JASN 15(12):3184–3191CrossRefPubMed

22.

Ruster C, Wolf G (2006) Renin–angiotensin–aldosterone system and progression of renal disease. JASN 17(11):2985–2991CrossRefPubMed

23.

Tsai CT, Lai LP, Lin JL et al (2004) Renin–angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109(13):1640–1646CrossRefPubMed

24.

Goette A, Staack T, Rocken C et al (2000) Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35(6):1669–1677CrossRefPubMed

25.

Kim YH, Lim DS, Lee JH et al (2003) Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35(5):336–349CrossRefPubMed

26.

Schlaich MP, Socratous F, Hennebry S et al (2009) Sympathetic activation in chronic renal failure. JASN 20(5):933–939CrossRefPubMed

27.

Carnagarin R, Kiuchi MG, Ho JK, Matthews VB, Schlaich MP (2018) Sympathetic nervous system activation and its modulation: role in atrial fibrillation. Front Neurosci 12:1058CrossRefPubMed

28.

Chimenti C, Russo MA, Carpi A, Frustaci A (2010) Histological substrate of human atrial fibrillation. Biomed Pharmacother 64(3):177–183CrossRefPubMed

29.

Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96(4):1180–1184CrossRefPubMed

30.

Nogueira A, Pires MJ, Oliveira PA (2017) Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. Vivo 31(1):1–22CrossRef

31.

Brunetti ND, Maulucci G, Casavecchia GP et al (2007) Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg. J Interv Cardiol 20(6):481–487CrossRefPubMed

32.

Dernellis J, Panaretou M (2005) Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 150(5):1064CrossRefPubMed

33.

Chang CH, Lee YC, Tsai CT et al (2014) Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis 232(1):224–230CrossRefPubMed

34.

Bianchi S, Bigazzi R, Caiazza A, Campese VM (2003) A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 41(3):565–570CrossRefPubMed

35.

Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345(12):861–869CrossRefPubMed

36.

Kawamura M, Ito H, Onuki T et al (2010) Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation. J Cardiovasc Pharmacol 55(5):511–517PubMed

37.

Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, Schmieder RE (2010) Prevention of atrial fibrillation by renin–angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 55(21):2299–2307CrossRefPubMed

Titel: Atrial fibrillation and kidney disease: insights on a close relationship
verfasst von: Giorgio Trivioli
Publikationsdatum: 17.07.2019
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 7/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-019-02141-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2019

Risk stratification in hospitalized heart failure patients: do the RIGHT thing!

Is circulating endothelin evaluation useful for clinicians?

Pyogenic liver abscess caused by accidental ingestion of a bottle cap

Daylight saving time transitions and circulatory deaths: data from the Veneto region of Italy

Multimodal oral analgesia for non-severe trauma patients: evaluation of a triage-nurse directed protocol combining methoxyflurane, paracetamol and oxycodone